ライフサイエンスコーパス: reduce the risk of

1 nment to 1 year of trastuzumab significantly reduced the risk of a disease-free survival event (HR 0.

2 Q-HDM and 12 SQ-HDM doses both significantly reduced the risk of a moderate or severe asthma exacerba

3 tion of donated blood products substantially reduces the risk of a number of transfusion-related comp

4 Treatment reduced the risk of active TB among the populations incl

5 Pioglitazone reduced the risk of acute coronary syndrome (hazard rati

6 tics, the use of cytolytic induction therapy reduced the risk of acute rejection by 32% (OR 0.68, 0.6

7 n-2-receptor antibody (IL-2RAb) induction in reducing the risk of acute rejection in adult kidney tra

8 on of a high number of different solid foods reduced the risk of AD (P trend = 0.02 at 4 months of ag

9 llergens to increase their effectiveness and reduce the risk of adverse events.

10 the concept that nitrate-rich vegetables may reduce the risk of age-related ASVD mortality.

11 nce and concentration in source manure would reduce the risk of AGI from exposure to manure irrigatio

12 atin treatment compared with placebo did not reduce the risk of AKI overall, among patients naive to

13 usion strategy might improve PCI outcomes by reducing the risk of AKI.

14 emic stroke as their index event, betrixaban reduced the risk of all-cause stroke (0.72% versus 1.48%

15 cillus Calmette-Guerin (BCG) vaccination may reduce the risk of allergic diseases, including atopic d

16 controlled trials) showed that cell therapy reduced the risk of amputation by 37%, improved amputati

17 iduals in the early stages of the disease to reduce the risk of an HIV pandemic.

18 lergens, to increase tolerance threshold, to reduce the risk of anaphylaxis, and to improve the patie

19 administration of insulin before surgery to reduce the risk of anesthesia-induced cognitive decline

20 ting increases targetable tumor antigens and reduces the risk of antigen-negative disease escape.

21 reatment constitutes a potential strategy to reduce the risk of antimicrobial resistance among childr

22 use of aspirin compared with placebo did not reduce the risk of ARDS at 7 days.

23 y suitable for targeting neuroanatomy, as it reduces the risk of artifacts and is faster than classic

24 polyunsaturated fatty acids in pregnancy can reduce the risk of asthma in offspring and allergic resp

25 e could take advantage of drugs and diets to reduce the risk of atherosclerotic diseases.

26 care, weight loss through bariatric surgery reduced the risk of atrial fibrillation among persons be

27 reducing BV, this PPT intervention may also reduce the risk of bacterial STI among women.

28 al diagnosis during reactive surveillance to reduce the risk of between-farm transmission.

29 nates bias.Although all these approaches can reduce the risk of bias in observational studies, none r

30 Tranexamic acid reduces the risk of bleeding among patients undergoing c

31 nated central venous catheters significantly reduced the risk of bloodstream infections compared with

32 ve been demonstrated in randomized trials to reduce the risk of both invasive and DCIS recurrence, bu

33 he mechanisms by which exercise training can reduce the risk of brain diseases, inform the optimizati

34 rs of cancer by health-care practitioners to reduce the risk of breast cancer-related lymphoedema are

35 aromatase inhibitor to 10 years may further reduce the risk of breast-cancer recurrence.

36 vestigated the effectiveness of tamoxifen in reducing the risk of breast cancer among women at increa

37 y be a simple, nonpharmacologic strategy for reducing the risk of breast cancer recurrence.

38 of evidence suggests that CMVIG prophylaxis reduces the risk of bronchiolitis obliterans syndrome, b

39 long-chain polyunsaturated fatty acid, might reduce the risk of bronchopulmonary dysplasia, but appro

40 ssion of Barrett's esophagus, and this might reduce the risk of cancer development.

41 s a mechanistic basis for targeting MDSCs to reduce the risk of cancer metastasis.

42 types of cancer; * Support policy efforts to reduce the risk of cancer through evidence-based strateg

43 supplementation with vitamin D3 and calcium reduces the risk of cancer among older women.

44 e research can help to better understand and reduce the risks of cannabis use.

45 ous physical exercise is an effective way to reduce the risk of cardiovascular (CV) disease, CAHAP re

46 frequently used in the elderly population to reduce the risk of cardiovascular disease.

47 ating relation with LC n-3 PUFAs and also to reduce the risk of cardiovascular diseases (CVDs).

48 Lowering both should reduce the risk of cardiovascular events substantially.

49 nt kidney disease at baseline, empagliflozin reduced the risk of cardiovascular death by 29% compared

50 0 mg per deciliter (0.78 mmol per liter) and reduced the risk of cardiovascular events.

51 ent with ticagrelor + low-dose aspirin (ASA) reduces the risk of cardiovascular (CV) death, MI, or st

52 Antihypertensive therapy reduces the risk of cardiovascular events among high-ris

53 that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons

54 otics closer to the first dose of antibiotic reduces the risk of CDI by >50% in hospitalized adults.

55 uantities of gluten at 4-6 mo of age did not reduce the risk of celiac disease (CD) in a group of hig

56 weaning to an extensively hydrolyzed formula reduced the risk of celiac disease autoimmunity or celia

57 ffective than SC-both at 6 mo and at 1 y-for reducing the risk of child wasting.

58 Siblings have been shown to reduce the risk of childhood asthma and allergy, but the

59 ional and sensorial quality and potential to reduce the risk of chronic diseases such as obesity and

60 hytochemicals confers benefits for health by reducing the risk of chronic diseases via regulation of

61 ffectively help slow disease progression and reduce the risk of cirrhosis, hepatocellular carcinoma (

62 with immune active chronic HBV infection in reducing the risk of cirrhosis, decompensated liver dise

63 Managed adaptation could reduce the risks of climate change to the world's ecosys

64 t budesonide (RR, 0.93; 95% CrI, 0.40-1.84), reduced the risk of clinical relapse.

65 ation therapy with ambrisentan and tadalafil reduces the risk of clinical failure events compared wit

66 tandard aortic cannula did not significantly reduce the risk of CNS infarction at 7 days.

67 cate prophylactic CNS-directed therapies may reduce the risk of CNS involvement; however, no consensu

68 atment with oral corticosteroids may help to reduce the risk of CNVM development, and anti-VEGF thera

69 lymphocyte depletion and repopulation could reduce the risk of CoBRR.

70 tive and CoB-resistant T cell populations to reduce the risk of CoBRR.

71 health in later life and offer potential to reduce the risk of cognitive decline and dementia.

72 nknown whether naturally acquired antibodies reduce the risk of colonization with strains expressing

73 ent regimens for children with ependymoma to reduce the risk of complications associated with therapy

74 roaches to further improve success rates and reduce the risks of complications are needed.

75 iagnosis, while preventive chemotherapy will reduce the risk of contacts developing the disease by 50

76 rbonate rather than isotonic sodium chloride reduces the risk of contrast-associated acute kidney inj

77 laparoscopic surgery, did not significantly reduce the risk of conversion to open laparotomy.

78 olled trial to determine whether minocycline reduces the risk of conversion from a first demyelinatin

79 d weight, long-term sulfonylurea therapy may reduce the risk of coronary heart disease.

80 viduals with LDL-C >/=190 mg/dL, pravastatin reduced the risk of coronary heart disease by 27% (P=0.0

81 iduals without vascular disease, pravastatin reduced the risk of coronary heart disease by 27% (P=0.0

82 entions could be preferentially effective in reducing the risk of coronary heart disease in individua

83 ral population findings, alcohol use may not reduce the risk of CVD in patients with NAFLD.

84 t reduce P loads alone may not significantly reduce the risk of cyanobacterial blooms in western Lake

85 for stable coronary artery disease does not reduce the risk of death and myocardial infarction compa

86 Reported small size at birth did not reduce the risk of death associated with anthropometric

87 ermia initiated at 6 to 24 hours after birth reduces the risk of death or disability at 18 months amo

88 cal device on the market and are believed to reduce the risk of deep vein thrombosis by 40%.

89 the cyclooxygenase enzymes COX-1 and COX-2, reduce the risk of developing Alzheimer's disease in nor

90 ave suggested that a flavonoid-rich diet can reduce the risk of developing cardiovascular disease.

91 To reduce the risk of developing depression, individuals sh

92 n equal amount of ASBs did not significantly reduce the risk of developing DM.

93 Although generic control measures to reduce the risk of developing or exacerbating asthma are

94 R) inhibitors called statins at mid-life can reduce the risk of developing sporadic Alzheimer's disea

95 s, providing a rationale to cotarget EGFR to reduce the risks of developing drug resistance.

96 of asthma rescue medications at cohort entry reduced the risk of developing obesity (hazard ratio, 0.

97 Living in a microbe-rich environment reduces the risk of developing asthma.

98 ype HLA-C2, expressed by fetal trophoblasts, reduces the risk of developing pregnancy complications.

99 Strategies aim to reduce the risk of DGF could potentially improve graft s

100 ty that GGT increases the risk of CAD/MI and reduces the risk of diabetes.

101 ied the efficacy of each control strategy in reducing the risks of different transmission routes.

102 d influenza immunisation during pregnancy to reduce the risk of disease for mother and infant.

103 n as possible in all HIV infected persons to reduce the risk of disease progression and prevent trans

104 ted neoadjuvant and adjuvant immunotherapies reduce the risk of disease relapse after resection of mu

105 m-related barriers to diabetes care may help reduce the risk of DR.

106 dherence to reprocessing protocols, may help reduce the risk of duodenoscope-associated infection tra

107 confirm that medical treatment substantially reduces the risk of early recurrent stroke after TIA and

108 Early intervention is needed to reduce the risk of endometriosis and infertility.

109 ptibility gene variant at rs6736278 (CAPN14) reduced the risk of EoE (adjusted odds ratio, 0.08; 95%

110 cts that are vital for these functions, thus reducing the risk of epilepsy surgery causing new morbid

111 e of depression and insomnia, a novel way to reduce the risk of escalating depression might be to off

112 Early-life cognitive enrichment may reduce the risk of experiencing cognitive deterioration

113 the SQ grass sublingual immunotherapy tablet reduced the risk of experiencing asthma symptoms and usi

114 ublingual immunotherapy tablet significantly reduced the risk of experiencing asthma symptoms or usin

115 while shock testing seems safe, it does not reduce the risk of failed shocks or prolong survival.

116 o increase the probabilities of survival and reduce the risk of failing to meet the minimum needs for

117 r (ChI) might improve cognitive function and reduce the risk of falls in patients with PD, although i

118 an greatly increase the confidence in calls, reduce the risk of false positives, and help characteriz

119 smoking, quitting areca nut chewing may also reduce the risk of first recurrence in NMBIC patients, m

120 rovements and developments have been made to reduce the risk of food contamination.

121 Assessing liver health may be important for reducing the risk of future CHF events, particularly amo

122 bacter pylori infection has been reported to reduce the risk of gastric cancer among asymptomatic ind

123 sis regimen available to most patients while reducing the risk of generating additional drug resistan

124 othesized that higher vitamin A levels would reduce the risk of graft-versus-host disease (GVHD) thro

125 fective strategies that may be considered to reduce the risk of having a child with developmental def

126 Additionally, metformin was effective in reducing the risk of HCC when compared with sulphonylure

127 Alumni", established that more strenuous PA reduced the risk of heart attack and that it was necessa

128 roved by physical activity, which might also reduce the risk of hepatic encephalopathy through an inc

129 The benefits of mesh for reducing the risk of hernia recurrence or the long-term

130 g the offspring of one breeding season while reducing the risk of hidden inbreeding due to related fo

131 Bisphosphonates (generic) and denosumab reduce the risk of hip, nonvertebral, and vertebral frac

132 daily as pre-exposure prophylaxis (PrEP) can reduce the risk of HIV infection by 49% in people who in

133 A monthly vaginal ring containing dapivirine reduced the risk of HIV-1 infection among African women,

134 phylaxis (PrEP) with tenofovir-emtricitabine reduces the risk of HIV infection.

135 ove the efficacy of public health efforts to reduce the risk of hormone-sensitive cancers and other n

136 ed left atrial pressure improve symptoms and reduce the risk of hospital admission.

137 Informed interventions could reduce the risk of human exposure to vector species with

138 on and interventions undertaken, to date, to reduce the risk of human infection through these routes.

139 aches has dramatically improved survival and reduced the risk of human herpesvirus 8 (HHV8)-associate

140 mption of egg protein from age 4 to 6 months reduces the risk of IgE-mediated egg allergy in infants

141 ing Mendelian randomization suggest that ALT reduces the risk of IHD, probably through reducing trigl

142 Supplement use reduces the risk of inadequate intake for many micronutr

143 achycardia therapy programming significantly reduced the risk of inappropriate ICD therapy compared w

144 Innovative ICD programming significantly reduces the risk of inappropriate ICD therapy in both IC

145 suggest that long-duration breastfeeding may reduce the risk of incident hypertension in middle age.

146 mmune globulin (IVIg) may be administered to reduce the risk of infection.

147 optisol-GS and should be further explored to reduce the risk of infection.

148 lp protect against pathogen colonization and reduce the risk of infection.

149 these biomarkers may enable interventions to reduce the risk of inflammatory complications following

150 Influenza vaccines reduced the risk of influenza illness in 2015-2016.

151 sults suggest that novel oral anticoagulants reduce the risk of intraocular bleeding by approximately

152 practices, wherein raising hemoglobin could reduce the risk of ischemia in a critically hypoperfused

153 Early probiotic supplementation may reduce the risk of islet autoimmunity in children at the

154 s, and possibly other short-term cachers, to reduce the risks of kleptoparasitism.

155 Similarly, pioglitazone reduced the risk of large MIs with serum troponin >100x

156 fluids, without the need of cold-storage and reducing the risks of leakage.

157 ve delivery spares surrounding normal liver, reducing the risk of liver failure.

158 reed that available evidence shows that PMRT reduces the risks of locoregional failure (LRF), any rec

159 ly diagnosis and management of HF could help reduce the risk of long-term renal complications.

160 H) in patients with hypertension and whether reducing the risk of LVH explains the reported cardiovas

161 Potent P2Y12 inhibitors significantly reduced the risk of MACE by 14% in women (hazard ratio [

162 impaired glucose tolerance, acarbose did not reduce the risk of major adverse cardiovascular events,

163 of losmapimod compared with placebo did not reduce the risk of major ischemic cardiovascular events.

164 iacin with laropiprant did not significantly reduce the risk of major vascular events and increased t

165 a sodium-glucose cotransporter 2 inhibitor, reduced the risk of major adverse cardiovascular events

166 Evolocumab reduced the risk of major adverse limb events in all pat

167 sity lipoprotein cholesterol with evolocumab reduced the risk of major adverse limb events.

168 ion in systolic blood pressure significantly reduced the risk of major cardiovascular disease events

169 randomised trials shows that statin therapy reduces the risk of major vascular events (ie, coronary

170 guided percutaneous coronary intervention in reducing the risk of major adverse cardiac events.

171 G3 in malaria immunity, and its transfer may reduce the risk of malaria in infancy.

172 Ticagrelor (pooled doses) reduced the risk of MALE (hazard ratio: 0.65; 95% confid

173 physical function, and quality of life, and reduce the risk of malnutrition in sarcopenic elderly pe

174 the treatment of various diseases, including reducing the risk of many chronic degenerative disorders

175 wering effect in humans and are important in reducing the risk of many chronic diseases.

176 mpts should continue to explore therapies to reduce the risk of mortality or hospitalization for thes

177 Oral anticoagulation reduces the risk of mortality in atrial fibrillation (AF

178 c dysfunction, biventricular pacing not only reduces the risk of mortality/morbidity, but also leads

179 hnoid hemorrhage met the primary endpoint of reducing the risk of mortality.

180 We conclude that PNT has the potential to reduce the risk of mtDNA disease, but it may not guarant

181 nd nonfatal heart failure events but did not reduce the risk of myocardial infarction or stroke in di

182 nd avoidance of bovine-origin products might reduce the risk of necrotising enterocolitis, but the ab

183 nd avoidance of bovine-origin products might reduce the risk of necrotising enterocolitis, but the ab

184 er weight loss through bariatric surgery may reduce the risk of new-onset atrial fibrillation.

185 LNS-PLs reduced the risk of newborn stunting (18.7% compared wit

186 Interventions targeting serum magnesium to reduce the risk of NODAT should be evaluated.

187 Teriparatide reduces the risk of nonvertebral and vertebral fractures

188 may make it possible to prevent or at least reduce the risk of norovirus outbreaks by closing potent

189 ed to T cells and natural killer (NK) cells, reducing the risk of off-target-organ toxicity.

190 is valid, bone preservative strategies could reduce the risk of osteoporosis/fractures among ICU surv

191 tion, not only reduces stroke risk, but also reduces the risk of other cardiovascular diseases.

192 ectomy is currently the only method known to reduce the risk of ovarian cancer-related death.

193 products, especially yogurt and cheese, may reduce the risk of overall and CVD mortality.

194 Rectal indomethacin reduces the risk of pancreatitis after endoscopic retrog

195 2.48]), and tetracycline therapy appeared to reduce the risk of Parkinson disease (adjusted IRR, 0.98

196 cated nurses working in acute care areas can reduce the risk of patient mortality, although the evide

197 developing interventions that substantially reduce the risk of PD-related peritonitis.

198 A temporary ileostomy may reduce the risk of pelvic sepsis after anastomotic dehis

199 h malignant obstruction, rectal indomethacin reduced the risk of PEP by 64% (OR, 0.36; 95% CI, 0.17-0

200 ion of and treatment for PTSD symptoms might reduce the risk of perinatal depression in post-conflict

201 (RR=1.98, 95% CI 1.64 to 2.38; p<0.001), and reduced the risks of periprocedural symptomatic intracra

202 -36 weeks gestation during each pregnancy to reduce the risk of pertussis to their infants.

203 ation of left ventricular diastolic function reduces the risk of PGD.

204 , adding monthly DP to daily TMP-SMX did not reduce the risk of placental or maternal malaria or impr

205 g cleaner burning biomass-fuelled cookstoves reduced the risk of pneumonia in young children in rural

206 g cleaner burning biomass-fuelled cookstoves reduced the risk of pneumonia in young children in rural

207 eurectomy at the time of hernia repair would reduce the risk of postoperative pain for open tension-f

208 pressure, compared with standard management, reduced the risk of postoperative organ dysfunction.

209 LR reduces the risk of postoperative mortality compared wit

210 thromycin was more effective than placebo in reducing the risk of postoperative infection.

211 l benefits of nepafenac 0.3% over vehicle in reducing the risk of postoperative ME, with the integrat

212 to maintain their desirable functions while reducing the risk of potential health hazards.

213 ld be one of the most scalable strategies to reduce the risk of premature mortality from atherosclero

214 Nations set key targets to reach by 2025 to reduce the risk of premature noncommunicable disease dea

215 er vaginal progesterone prophylaxis given to reduce the risk of preterm birth affects neonatal and ch

216 rogesterone administration has been shown to reduce the risk of preterm birth and neonatal morbidity

217 intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia.

218 whether a pessary inserted around the cervix reduces the risk of preterm singleton birth.

219 subjects with early/mild COPD to potentially reduce the risk of progressing to more advanced lung dis

220 Enzalutamide reduced the risk of progression or death by 76% compared

221 This treatment combination reduced the risk of progression or death by 87% versus d

222 eutic and diagnostic radiation treatments to reduce the risk of radiation-related adverse systemic ef

223 irmed this effect modification: atorvastatin reduced the risk of reaching the primary endpoint in the

224 duction in PP, which may have contributed to reduce the risk of rebleeding and of further decompensat

225 OP, an air tamponade duration beyond 2 hours reduced the risk of rebubbling (HR 0.36 [95% CI 0.18-0.7

226 s leucovorin (FU + LV) adjuvant chemotherapy reduced the risk of recurrence and death across all time

227 e, the use of anakinra compared with placebo reduced the risk of recurrence over a median of 14 month

228 Addition of oxaliplatin significantly reduced the risk of recurrence within the first 14 month

229 emotherapy with fluoropyrimidine monotherapy reduces the risk of recurrence and death by approximatel

230 for estrogen receptor-positive breast cancer reduces the risk of recurrence by approximately one-half

231 Whether closure of a patent foramen ovale reduces the risk of recurrence of ischemic stroke in pat

232 otherapy (RT) after lumpectomy significantly reduces the risk of recurrence.

233 3 to 5 years was not found to significantly reduce the risk of recurrent colorectal adenomas in a re

234 otide, a somatostatin analog, is proposed to reduce the risk of recurrent GI bleeding in this populat

235 , adding ticagrelor to aspirin significantly reduces the risk of recurrent ischemic events, including

236 ential reintroduction sites is important for reducing the risk of reintroduction failure of endangere

237 en compared with conventional oxygen therapy reduced the risk of reintubation within 72 hours.

238 hereditary liver diseases, which may likely reduce the risk of rejection and the need for lifelong i

239 induction therapy, as compared with IL-2RA, reduces the risk of rejection, graft loss, and death in

240 ogous stem-cell transplantation (autoSCT) to reduce the risk of relapse, although the benefit of this

241 analysis of the efficacy of this approach in reducing the risk of relapse in major depressive disorde

242 ontrolled manner and has to be considered to reduce the risk of retinal break formation and to preven

243 e can prevent ZIKV disease and be adapted to reduce the risk of sensitizing individuals to subsequent

244 hese defects may improve T cell function and reduce the risk of sepsis.

245 hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days.

246 Proton pump inhibitors (PPIs) might reduce the risk of serious warfarin-related upper gastro

247 ic BP lowering to a target of <130 mm Hg may reduce the risk of several important outcomes including

248 onsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk of several cancers, but it is not clear

249 INTERPRETATION: Immediate ART reduces the risk of several severe bacterial infections

250 pendent eye in the lateral tilt position may reduce the risk of severe corneal injury.

251 This variant reduces the risk of severe malaria by 40% and has recent

252 he elimination of cardiopulmonary bypass may reduce the risk of short-term mortality, renal failure,

253 d the requirement for long-term treatment to reduce the risk of significant bleeding events.

254 nistered to patients with bone metastases to reduce the risk of skeletal-related events (SREs).

255 It is unclear if a cervical pessary can reduce the risk of spontaneous preterm delivery.

256 ng antibiotics from animal diets and thereby reducing the risk of spreading antibiotic resistance ass

257 whether the use of aspirin and other NSAIDS reduces the risk of squamous cell carcinoma (SCC), we co

258 Conclusion ZA every 3 months was more CE in reducing the risks of SRE than monthly denosumab.

259 ry 3 months was noninferior to monthly ZA in reducing the risks of SREs.

260 administration of SAP did not significantly reduce the risk of SSI compared with late administration

261 Labor induction may reduce the risk of stillbirth, but it also may increase

262 s with the factor Xa inhibitor betrixaban to reduce the risk of stroke compared with standard-dose en

263 rformed during cardiac surgery ostensibly to reduce the risk of stroke.

264 l anticoagulation with vitamin K antagonists reduces the risk of stroke by more than 60%.

265 ing patients with acute stroke for dysphagia reduces the risk of stroke-associated pneumonia (SAP), o

266 To reduce the risk of subsequent metastatic disease, system

267 Overall, filters appear to reduce the risk of subsequent PE, increase the risk for

268 In all subgroups, filter use did not reduce the risk of subsequent pulmonary embolism.

269 Although early and delayed CCY equally reduce the risk of subsequent recurrent biliary events,

270 enom immunotherapy (VIT) could substantially reduce the risk of subsequent severe systemic sting reac

271 ntervention; however, stenting significantly reduces the risk of subsequent pulmonary vein restenosis

272 equate adherence to recommendations known to reduce the risk of sudden unexpected infant death has co

273 ort for referring otolaryngologists and help reduce the risk of surgical complications.

274 enous cefazolin compared with saline did not reduce the risk of surgical site infection within 30 day

275 interface to achieve systemic levels, while reducing the risk of systemic toxicity seen with parenta

276 for strengthening primary care provision and reducing the risks of systems failures were then identif

277 d to consider dietary supplements that might reduce the risk of the disease progressing from the inte

278 idly removes thrombus and is hypothesized to reduce the risk of the post-thrombotic syndrome.

279 placebo, evolocumab treatment significantly reduced the risk of the primary end point (1344 patients

280 e risk of cardiovascular events primarily by reducing the risk of the development or progression of h

281 effective surveillance is a key strategy to reduce the risk of their establishment.

282 ing or enhancing mechanical properties while reducing the risk of thrombogenesis.

283 py (DAPT) with a P2Y12 inhibitor and aspirin reduces the risk of thrombosis and stroke but increases

284 of NIV compared with standard oxygen therapy reduced the risk of tracheal reintubation within 7 days.

285 rkers for targeted agents, and strategies to reduce the risk of transformation.

286 with an restrictive transfusion protocol did reduce the risk of transfusion in moderately anemic pati

287 s crucial to improve health interventions to reduce the risk of transmission between pigs and from pi

288 suggesting that slaughter interventions may reduce the risk of transmission of ARDs to beef consumer

289 the early stages of the disease in order to reduce the risk of transmission to other humans.

290 ol can complement preventive chemotherapy by reducing the risk of transmission from snails to humans.

291 innate and adaptive immunity can effectively reduce the risk of tumor recurrence after surgery, facil

292 An aim of weight loss is to reduce the risk of type 2 diabetes (T2D) in obese subjec

293 Plant-based diets have been recommended to reduce the risk of type 2 diabetes (T2D).

294 A diet that is low in AGEs may reduce the risk of type 2 diabetes by increasing insulin

295 Pioglitazone also reduced the risk of type 1 MI (hazard ratio, 0.62; 95% c

296 pecific antithrombotic therapy post-TAVR may reduce the risk of VHD.

297 radiation, as a safe and effective method to reduce the risk of viral transmission.

298 virological monitoring might be necessary to reduce the risk of virological failure.

299 rapaxar and ticagrelor pooled) significantly reduced the risk of VTE by 29% compared with background

300 More intensive antiplatelet therapy reduces the risk of VTE.